150 related articles for article (PubMed ID: 30786739)
1. Choosing a Mouse Model of Venous Thrombosis.
Diaz JA; Saha P; Cooley B; Palmer OR; Grover SP; Mackman N; Wakefield TW; Henke PK; Smith A; Lal BK
Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):311-318. PubMed ID: 30786739
[TBL] [Abstract][Full Text] [Related]
2. Choosing a mouse model of venous thrombosis: a consensus assessment of utility and application.
Diaz JA; Saha P; Cooley B; Palmer OR; Grover SP; Mackman N; Wakefield TW; Henke PK; Smith A; Lal BK
J Thromb Haemost; 2019 Apr; 17(4):699-707. PubMed ID: 30927321
[TBL] [Abstract][Full Text] [Related]
3. Critical review of mouse models of venous thrombosis.
Diaz JA; Obi AT; Myers DD; Wrobleski SK; Henke PK; Mackman N; Wakefield TW
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):556-62. PubMed ID: 22345593
[TBL] [Abstract][Full Text] [Related]
4. By word of mouse: using animal models in venous thrombosis research.
Campos J; Brill A
Platelets; 2020 May; 31(4):447-454. PubMed ID: 31625437
[TBL] [Abstract][Full Text] [Related]
5. Edoxaban improves venous thrombosis via increasing hydrogen sulfide and homocysteine in rat model.
Song W; Ci H; Tian G; Zhang Y; Ge X
Mol Med Rep; 2017 Nov; 16(5):7706-7714. PubMed ID: 28944880
[TBL] [Abstract][Full Text] [Related]
6. Ferric chloride thrombosis model: unraveling the vascular effects of a highly corrosive oxidant.
Schoenwaelder SM; Jackson SP
Blood; 2015 Dec; 126(24):2652-3. PubMed ID: 26504184
[No Abstract] [Full Text] [Related]
7. Atherosclerotic plaque injury-mediated murine thrombosis models: advantages and limitations.
Karel M; Hechler B; Kuijpers M; Cosemans J
Platelets; 2020 May; 31(4):439-446. PubMed ID: 31957516
[TBL] [Abstract][Full Text] [Related]
8. In vivo characterization of the murine venous system before and during dobutamine stimulation: implications for preclinical models of venous disease.
Palmer OR; Chiu CB; Cao A; Scheven UM; Diaz JA; Greve JM
Ann Anat; 2017 Nov; 214():43-52. PubMed ID: 28865773
[TBL] [Abstract][Full Text] [Related]
9. Mouse models of focal arterial and venous thrombosis.
Dörffler-Melly J; Schwarte LA; Ince C; Levi M
Basic Res Cardiol; 2000 Dec; 95(6):503-9. PubMed ID: 11192373
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide augments venous and arterial thrombosis in the mouse.
Wang X
Thromb Res; 2008; 123(2):355-60. PubMed ID: 18448153
[TBL] [Abstract][Full Text] [Related]
11. Endothelial progenitor cell-derived exosomes, loaded with miR-126, promoted deep vein thrombosis resolution and recanalization.
Sun J; Zhang Z; Ma T; Yang Z; Zhang J; Liu X; Lu D; Shen Z; Yang J; Meng Q
Stem Cell Res Ther; 2018 Aug; 9(1):223. PubMed ID: 30139377
[TBL] [Abstract][Full Text] [Related]
12. The aetiology of deep venous thrombosis.
Malone PC; Agutter PS
QJM; 2006 Sep; 99(9):581-93. PubMed ID: 16905749
[TBL] [Abstract][Full Text] [Related]
13. How useful are ferric chloride models of arterial thrombosis?
Grover SP; Mackman N
Platelets; 2020 May; 31(4):432-438. PubMed ID: 31608756
[TBL] [Abstract][Full Text] [Related]
14. Microcirculatory alterations in a Mongolian gerbil sinus-vein thrombosis model.
Miyamoto K; Heimann A; Kempski O
J Clin Neurosci; 2001 May; 8 Suppl 1():97-105. PubMed ID: 11386836
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and diagnosis of deep venous thrombosis.
Line BR
Semin Nucl Med; 2001 Apr; 31(2):90-101. PubMed ID: 11330789
[TBL] [Abstract][Full Text] [Related]
16. Decreased venous thrombosis with an oral inhibitor of P selectin.
Myers DD; Rectenwald JE; Bedard PW; Kaila N; Shaw GD; Schaub RG; Farris DM; Hawley AE; Wrobleski SK; Henke PK; Wakefield TW
J Vasc Surg; 2005 Aug; 42(2):329-36. PubMed ID: 16102635
[TBL] [Abstract][Full Text] [Related]
17. Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis.
Wang X; Smith PL; Hsu MY; Tamasi JA; Bird E; Schumacher WA
J Thromb Thrombolysis; 2007 Feb; 23(1):41-9. PubMed ID: 17111204
[TBL] [Abstract][Full Text] [Related]
18. Towards a standardization of the murine ferric chloride-induced carotid arterial thrombosis model.
Owens AP; Lu Y; Whinna HC; Gachet C; Fay WP; Mackman N
J Thromb Haemost; 2011 Sep; 9(9):1862-3. PubMed ID: 21884567
[No Abstract] [Full Text] [Related]
19. Acute venous disease: venous thrombosis and venous trauma.
Meissner MH; Wakefield TW; Ascher E; Caprini JA; Comerota AJ; Eklof B; Gillespie DL; Greenfield LJ; He AR; Henke PK; Hingorani A; Hull RD; Kessler CM; McBane RD; McLafferty R
J Vasc Surg; 2007 Dec; 46 Suppl S():25S-53S. PubMed ID: 18068560
[TBL] [Abstract][Full Text] [Related]
20. Ranking the contributing risk factors in venous thrombosis in terms of therapeutic potential: Virchow's triad revisited.
Kiyomura M; Katayama T; Kusanagi Y; Ito M
J Obstet Gynaecol Res; 2006 Apr; 32(2):216-23. PubMed ID: 16594928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
